세계의 안과용 봉합사 시장 규모, 점유율, 동향 분석 리포트 : 유형별, 흡수 능력별, 용도별, 최종 용도별, 지역별, 부문별 예측(2025-2030년)

Ophthalmic Sutures Market Growth & Trends:

The global ophthalmic sutures market size is expected to reach USD 706.5 million by 2030, registering a CAGR of 7.2% from 2025 to 2030, according to a new report by Grand View Research, Inc. Key factors driving the market are rising geriatric population prone to eye-related disorders, coupled with increasing awareness regarding advanced surgical procedures. Increasing aging population is expected to contribute to the rising burden of glaucoma around the world. According to the American Society of Ophthalmology, cataract alone affected over 24.4 million Americans aged 40 or more in 2016.

Visual impairment is a global health concern. According WHO, it is estimated that around 1.3 million people live with some form of vision impairment currently. Technological advancements in the field of ophthalmology, such as self-sealing incisions, are expected to fuel market growth. Other factors driving the market are increasing awareness about various eye diseases, coupled with increasing number of ophthalmologists and better reimbursement policies.

Various government initiatives, increasing investments in research and development, and rising healthcare spending are also expected to propel the market over the forecast period. Furthermore, increasing number of ambulatory surgical centers and single-day surgeries is expected to propel the market. Most of the ophthalmic procedures are single-day surgeries, which do not require hospital stay. Thus, with increasing number of outpatient surgeries, the ophthalmic sutures market is expected to witness lucrative growth over the forecast period.

Ophthalmic Sutures Market Report Highlights:

• The synthetic sutures segment of the ophthalmic sutures captured the largest market share of over 66.7% in 2024.
• The cataract surgery segment dominated the market with a market share of 39.5% in 2024. This growth is primarily driven by the rising incidence of visual impairment due to cataracts.
• The non-absorbable sutures segment captured the majority of market share at 59.4% in the ophthalmic sutures market in 2024. Non-absorbable sutures are commonly made from synthetic materials like polypropylene, nylon, and polyester, or natural materials such as silk and linen.
• The ambulatory surgical centers segment accounted for the largest share of 44.5% in 2024 owing to the increasing number of surgeries being performed in these centers.
• The North America ophthalmic sutures market held the largest share of the global ophthalmic sutures market at 38.6% in 2024 driven by factors such as the high prevalence of eye diseases, including cataracts, glaucoma, and diabetic retinopathy.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Segment Definitions
  • 1.2.1. Type
  • 1.2.2. Absorption Capacity
  • 1.2.3. Application
  • 1.2.4. End Use
  • 1.2.5. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Type outlook
  • 2.2.2. Absorption capacity outlook
  • 2.2.3. Application outlook
  • 2.2.4. End use outlook
• 2.3. Regional outlook
• 2.4. Competitive Insights

Chapter 3. Ophthalmic Sutures Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Rising aging population
    • 3.2.1.2. Increasing incidence of visual impairment
    • 3.2.1.3. Increasing awareness about an eye disorder
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. High cost of treatment
    • 3.2.2.2. Lack of skilled professionals
• 3.3. Ophthalmic Sutures Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Environmental landscape
    • 3.3.2.6. Legal landscape

Chapter 4. Ophthalmic Sutures Market: Type Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Ophthalmic Sutures Market: Type Movement Analysis
• 4.3. Ophthalmic Sutures Market by Type Outlook (USD Million)
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 4.5. Natural
  • 4.5.1. Natural Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.6. Synthetic
  • 4.6.1. Synthetic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Ophthalmic Sutures Market: Absorption Capacity Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Ophthalmic Sutures Market: Absorption Capacity Movement Analysis
• 5.3. Ophthalmic Sutures Market by Absorption Capacity Outlook (USD Million)
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 5.5. Absorbable Sutures
  • 5.5.1. Absorbable Sutures Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.6. Non-absorbable Sutures
  • 5.6.1. Non-absorbable Sutures Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Ophthalmic Sutures Market: Application Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Ophthalmic Sutures Market: Application Movement Analysis
• 6.3. Ophthalmic Sutures Market by Application Outlook (USD Million)
• 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 6.5. Corneal Transplantation Surgery
  • 6.5.1. Corneal Transplantation Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. Cataract Surgery
  • 6.6.1. Cataract Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.7. Vitrectomy Surgery
  • 6.7.1. Vitrectomy Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.8. Iridectomy Surgery
  • 6.8.1. Iridectomy Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.9. Oculoplastic Surgery
  • 6.9.1. Oculoplastic Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.10. Others
  • 6.10.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Ophthalmic Sutures Market: End Use Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Ophthalmic Sutures Market: End Use Movement Analysis
• 7.3. Ophthalmic Sutures Market by End Use Outlook (USD Million)
• 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 7.5. Hospitals
  • 7.5.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.6. Ambulatory Surgical Centers
  • 7.6.1. Ambulatory Surgical Centers Companies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.7. Others
  • 7.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Ophthalmic Sutures Market: Regional Estimates & Trend Analysis

• 8.1. Regional Market Share Analysis, 2024 & 2030
• 8.2. Regional Market Dashboard
• 8.3. Global Regional Market Snapshot
• 8.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 8.5. North America
  • 8.5.1. U.S.
    • 8.5.1.1. Key country dynamics
    • 8.5.1.2. Regulatory framework/ reimbursement structure
    • 8.5.1.3. Competitive scenario
    • 8.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.2. Canada
    • 8.5.2.1. Key country dynamics
    • 8.5.2.2. Regulatory framework/ reimbursement structure
    • 8.5.2.3. Competitive scenario
    • 8.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.3. Mexico
    • 8.5.3.1. Key country dynamics
    • 8.5.3.2. Regulatory framework/ reimbursement structure
    • 8.5.3.3. Competitive scenario
    • 8.5.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
• 8.6. Europe
  • 8.6.1. UK
    • 8.6.1.1. Key country dynamics
    • 8.6.1.2. Regulatory framework/ reimbursement structure
    • 8.6.1.3. Competitive scenario
    • 8.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.2. Germany
    • 8.6.2.1. Key country dynamics
    • 8.6.2.2. Regulatory framework/ reimbursement structure
    • 8.6.2.3. Competitive scenario
    • 8.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.3. France
    • 8.6.3.1. Key country dynamics
    • 8.6.3.2. Regulatory framework/ reimbursement structure
    • 8.6.3.3. Competitive scenario
    • 8.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.4. Italy
    • 8.6.4.1. Key country dynamics
    • 8.6.4.2. Regulatory framework/ reimbursement structure
    • 8.6.4.3. Competitive scenario
    • 8.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.5. Spain
    • 8.6.5.1. Key country dynamics
    • 8.6.5.2. Regulatory framework/ reimbursement structure
    • 8.6.5.3. Competitive scenario
    • 8.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.6. Norway
    • 8.6.6.1. Key country dynamics
    • 8.6.6.2. Regulatory framework/ reimbursement structure
    • 8.6.6.3. Competitive scenario
    • 8.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.7. Sweden
    • 8.6.7.1. Key country dynamics
    • 8.6.7.2. Regulatory framework/ reimbursement structure
    • 8.6.7.3. Competitive scenario
    • 8.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.8. Denmark
    • 8.6.8.1. Key country dynamics
    • 8.6.8.2. Regulatory framework/ reimbursement structure
    • 8.6.8.3. Competitive scenario
    • 8.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 8.7. Asia Pacific
  • 8.7.1. Japan
    • 8.7.1.1. Key country dynamics
    • 8.7.1.2. Regulatory framework/ reimbursement structure
    • 8.7.1.3. Competitive scenario
    • 8.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.2. China
    • 8.7.2.1. Key country dynamics
    • 8.7.2.2. Regulatory framework/ reimbursement structure
    • 8.7.2.3. Competitive scenario
    • 8.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.3. India
    • 8.7.3.1. Key country dynamics
    • 8.7.3.2. Regulatory framework/ reimbursement structure
    • 8.7.3.3. Competitive scenario
    • 8.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.4. Australia
    • 8.7.4.1. Key country dynamics
    • 8.7.4.2. Regulatory framework/ reimbursement structure
    • 8.7.4.3. Competitive scenario
    • 8.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.5. South Korea
    • 8.7.5.1. Key country dynamics
    • 8.7.5.2. Regulatory framework/ reimbursement structure
    • 8.7.5.3. Competitive scenario
    • 8.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.6. Thailand
    • 8.7.6.1. Key country dynamics
    • 8.7.6.2. Regulatory framework/ reimbursement structure
    • 8.7.6.3. Competitive scenario
    • 8.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 8.8. Latin America
  • 8.8.1. Brazil
    • 8.8.1.1. Key country dynamics
    • 8.8.1.2. Regulatory framework/ reimbursement structure
    • 8.8.1.3. Competitive scenario
    • 8.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.8.2. Argentina
    • 8.8.2.1. Key country dynamics
    • 8.8.2.2. Regulatory framework/ reimbursement structure
    • 8.8.2.3. Competitive scenario
    • 8.8.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 8.9. Middle East & Africa
  • 8.9.1. South Africa
    • 8.9.1.1. Key country dynamics
    • 8.9.1.2. Regulatory framework/ reimbursement structure
    • 8.9.1.3. Competitive scenario
    • 8.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.9.2. Saudi Arabia
    • 8.9.2.1. Key country dynamics
    • 8.9.2.2. Regulatory framework/ reimbursement structure
    • 8.9.2.3. Competitive scenario
    • 8.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.9.3. UAE
    • 8.9.3.1. Key country dynamics
    • 8.9.3.2. Regulatory framework/ reimbursement structure
    • 8.9.3.3. Competitive scenario
    • 8.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.9.4. Kuwait
    • 8.9.4.1. Key country dynamics
    • 8.9.4.2. Regulatory framework/ reimbursement structure
    • 8.9.4.3. Competitive scenario
    • 8.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Recent Developments & Impact Analysis, By Key Market Participants
• 9.2. Company/Competition Categorization
  • 9.2.1. Innovators
• 9.3. Vendor Landscape
  • 9.3.1. List of key distributors and channel partners
  • 9.3.2. Key customers
  • 9.3.3. Key company market share analysis, 2024
  • 9.3.4. Accutome Inc.
    • 9.3.4.1. Company overview
    • 9.3.4.2. Financial performance
    • 9.3.4.3. Type benchmarking
    • 9.3.4.4. Strategic initiatives
  • 9.3.5. Asset Medical Sarl
    • 9.3.5.1. Company overview
    • 9.3.5.2. Financial performance
    • 9.3.5.3. Type benchmarking
    • 9.3.5.4. Strategic initiatives
  • 9.3.6. Alcon Inc.
    • 9.3.6.1. Company overview
    • 9.3.6.2. Financial performance
    • 9.3.6.3. Type benchmarking
    • 9.3.6.4. Strategic initiatives
  • 9.3.7. Aurolab
    • 9.3.7.1. Company overview
    • 9.3.7.2. Financial performance
    • 9.3.7.3. Type benchmarking
    • 9.3.7.4. Strategic initiatives
  • 9.3.8. B Braun Melsungen AG
    • 9.3.8.1. Company overview
    • 9.3.8.2. Financial performance
    • 9.3.8.3. Type benchmarking
    • 9.3.8.4. Strategic initiatives
  • 9.3.9. DemeTech Corporation
    • 9.3.9.1. Company overview
    • 9.3.9.2. Financial performance
    • 9.3.9.3. Type benchmarking
    • 9.3.9.4. Strategic initiatives
  • 9.3.10. FCI Ophthalmic Inc.
    • 9.3.10.1. Company overview
    • 9.3.10.2. Financial performance
    • 9.3.10.3. Type benchmarking
    • 9.3.10.4. Strategic initiatives
  • 9.3.11. Medtronic Plc
    • 9.3.11.1. Company overview
    • 9.3.11.2. Financial performance
    • 9.3.11.3. Type benchmarking
    • 9.3.11.4. Strategic initiatives
  • 9.3.12. Rumex International Co.
    • 9.3.12.1. Company overview
    • 9.3.12.2. Financial performance
    • 9.3.12.3. Type benchmarking
    • 9.3.12.4. Strategic initiatives
  • 9.3.13. Surgical Specialties Corp
    • 9.3.13.1. Company overview
    • 9.3.13.2. Financial performance
    • 9.3.13.3. Type benchmarking
    • 9.3.13.4. Strategic initiatives
  • 9.3.14. Teleflex Incorporated
    • 9.3.14.1. Company overview
    • 9.3.14.2. Financial performance
    • 9.3.14.3. Type benchmarking
    • 9.3.14.4. Strategic initiatives
  • 9.3.15. Unilever.
    • 9.3.15.1. Company overview
    • 9.3.15.2. Financial performance
    • 9.3.15.3. Type benchmarking
    • 9.3.15.4. Strategic initiatives